111, Inc. Sponsored ADR (NASDAQ:YI) Stock Short Interest Jumps 204.2%

111, Inc. Sponsored ADR (NASDAQ:YI – Get Free Report) was the target of a significant increase in short interest in the month of October. As of October 30th, there was short interest totaling 13,122 shares, an increase of 204.2% from the October 15th total of 4,313 shares. Currently, 0.3% of the company’s shares are short sold. Based on an average daily trading volume, of 18,014 shares, the short-interest ratio is currently 0.7 days.

Analyst Ratings Changes

Separately, Weiss Ratings raised shares of 111 from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, November 2nd. One research analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, the stock has a consensus rating of “Sell”.

Check Out Our Latest Research Report on YI

111 Stock Performance

Shares of NASDAQ YI traded down $0.01 during midday trading on Friday, hitting $2.84. 4,258 shares of the company traded hands, compared to its average volume of 17,801. 111 has a 12-month low of $2.48 and a 12-month high of $11.17. The stock has a 50-day moving average price of $3.22 and a 200 day moving average price of $4.93. The firm has a market cap of $24.96 million, a P/E ratio of -1.77 and a beta of 0.78.

111 (NASDAQ:YI – Get Free Report) last issued its quarterly earnings data on Friday, September 18th. The company reported ($0.60) EPS for the quarter. The company had revenue of $338.55 million during the quarter.

111 Company Profile

(Get Free Report)

111, Inc. is a China-based digital healthcare company that connects pharmaceutical manufacturers, distributors, pharmacies, healthcare providers and consumers through online platforms and technology-enabled services. The company operates a pharmaceutical business-to-business platform that supplies medicines and healthcare products to pharmacies and other customers. It also offers online pharmacy services and digital tools intended to support purchasing, inventory management and other pharmacy operations.

Further Reading

Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.